News

Enhancing DEX Liquidity: Orderly's New Collaboration with Monad

Enhancing DEX Liquidity: Orderly's New Collaboration with Monad

Orderly Enhances Blockchain Liquidity Through Monad Integration

Orderly, a prominent player in the decentralized finance (DeFi) landscape, has taken a significant step towards augmenting liquidity across various blockchains by integrating its omnichain liquidity infrastructure with Monad, a high-performance EVM Layer 1 blockchain. This partnership aims to provide developers within the Monad ecosystem with immediate access to robust liquidity tailored for their projects.

Benefits of Integration: A Unified Liquidity Experience

With this powerful integration, developers accessing Orderly’s infrastructure can utilize an advanced software development kit (SDK) that allows them to leverage a single order book for cross-chain liquidity. The unique architecture of Orderly, supported by over 20 professional market makers including Wintermute, Selini, and Riverside, enhances market depth and minimizes spreads for decentralized exchanges (DEXes) and perpetual protocols. This initiative not only boosts trading efficiency but also enriches the overall user experience.

Supporting Diverse Blockchain Networks

Orderly is committed to supporting a wide array of both EVM and non-EVM chains, including popular networks such as Ethereum, Polygon, Arbitrum, Optimism, Base, Mantle, and Solana. The integration with Monad aligns seamlessly with Orderly’s mission of connecting with promising and emerging blockchains. As a result, DeFi developers and users can access extensive cross-chain liquidity, empowering them to create innovative trading applications that provide a seamless trading experience.

Voices from the Co-Founders

Ran Yi, Co-Founder of Orderly, expressed enthusiasm for this collaboration, emphasizing the distinct features of Monad in the often crowded EVM landscape. He highlighted Monad's unique combination of familiar tools and superior speed, noting the potential for revolutionary trading applications to emerge from this partnership. Yi is keen to see how developers will creatively utilize Orderly's omnichain liquidity to enhance their projects.

Monad Foundation's Perspective on the Collaboration

Kevin McCordic, Director of Growth at the Monad Foundation, echoed these sentiments, explaining that integrating Orderly’s liquidity infrastructure equips developers with immediate access to deep liquidity. He emphasized that Monad’s architecture is designed for speed and efficiency, which is vital as decentralized trading applications scale. Both teams share a vision of a more innovative DeFi space fostered by this integration.

Exploring Opportunities with Monad

This integration also presents unique opportunities for Orderly users. By connecting with the Monad blockchain, users have the chance to engage with a high-performance EVM chain and may even benefit from upcoming airdrops associated with its Layer 1 launch. The excitement is building around the impending release of Monad's testnet, which will allow developers to harness powerful trading solutions without the challenge of securing liquidity.

A Vision for Interconnected DeFi Landscapes

The integration of Orderly’s cross-chain liquidity with Monad marks a significant stride towards building an interconnected DeFi ecosystem that prioritizes user experience. As decentralized finance continues to evolve, such collaborations will play a crucial role in ensuring that liquidity is accessible and efficient across various platforms.

Frequently Asked Questions

What is the purpose of Orderly's integration with Monad?

The integration aims to provide developers in the Monad ecosystem with access to robust, efficient liquidity, allowing easy creation of decentralized trading applications.

How does Orderly’s architecture enhance trading?

Orderly's architecture integrates an advanced SDK and a unified order book, enabling deeper market depth through support from professional market makers.

Which blockchain networks does Orderly support?

Orderly supports various EVM and non-EVM chains, including Ethereum, Polygon, Solana, Arbitrum, and many more.

What benefits will users receive from this integration?

Users will gain access to high-performance EVM capabilities and may benefit from potential airdrops as Monad launches its testnet.

What is the long-term vision for Orderly and Monad?

Both companies envision creating an interconnected DeFi landscape that enhances user experience and fosters innovation through seamless liquidity access.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading